Publicaciones en colaboración con investigadores/as de Clínica Universitaria de Navarra (139)

2024

  1. Mass spectrometry in clinical protein laboratories

    Advances in Laboratory Medicine

2023

  1. Association between COVID-19 and outstanding academic performance at a Spanish university

    Archives of Public Health, Vol. 81, Núm. 1

  2. Detailed dosimetric evaluation of inter-fraction and respiratory motion in lung stereotactic body radiation therapy based on daily 4D cone beam CT images

    Physics in Medicine and Biology, Vol. 68, Núm. 1

  3. The Lymphatic Endothelium in the Context of Radioimmuno-Oncology

    Cancers, Vol. 15, Núm. 1

2022

  1. Design and validation of a tunable inertial microfluidic system for the efficient enrichment of circulating tumor cells in blood

    Bioengineering and Translational Medicine, Vol. 7, Núm. 3

  2. Stratification of radiosensitive brain metastases based on an actionable S100A9/RAGE resistance mechanism

    Nature medicine, Vol. 28, Núm. 4, pp. 752-765

  3. Tumor ENPP1 (CD203a)/Haptoglobin Axis Exploits Myeloid-Derived Suppressor Cells to Promote Post-Radiotherapy Local Recurrence in Breast Cancer

    Cancer Discovery, Vol. 12, Núm. 5, pp. 1356-1377

2021

  1. A method using 4D dose accumulation to quantify the interplay effect in lung stereotactic body radiation therapy

    Physics in Medicine and Biology, Vol. 66, Núm. 3

  2. Clinical trial of a rehabilitation device based on electrical stimulation for patients with obstructive sleep apnoea (OSA): a study protocol [version 1; peer review: awaiting peer review]

    F1000Research, Vol. 10, pp. 1-13

  3. Diffuse myocardial fibrosis: mechanisms, diagnosis and therapeutic approaches

    Nature Reviews Cardiology, Vol. 18, Núm. 7, pp. 479-498

  4. Dual Targeting of G9a and DNA Methyltransferase-1 for the Treatment of Experimental Cholangiocarcinoma

    Hepatology, Vol. 73, Núm. 6, pp. 2380-2396

  5. SRC family kinase (SFK) inhibitor dasatinib improves the antitumor activity of anti-PD-1 in NSCLC models by inhibiting Treg cell conversion and proliferation

    Journal for ImmunoTherapy of Cancer, Vol. 9, Núm. 3

2020

  1. Assessment of minimal residual disease by next generation sequencing in peripheral blood as a complementary tool for personalized transplant monitoring in myeloid neoplasms

    Journal of Clinical Medicine, Vol. 9, Núm. 12, pp. 1-20

  2. Continuous intraocular pressure monitoring in patients with obstructive sleep apnea syndrome using a contact lens sensor

    PLoS ONE, Vol. 15, Núm. 3

  3. Exploring the association between emphysema phenotypes and low bone mineral density in smokers with and without copd

    International Journal of COPD, Vol. 15, pp. 1823-1829

  4. Plzf-rarα, npm1-rarα, and other acute promyelocytic leukemia variants: The pethema registry experience and systematic literature review

    Cancers, Vol. 12, Núm. 5

  5. Prenatal Exposure to Perfluoroalkyl Substances Associated With Increased Susceptibility to Liver Injury in Children

    Hepatology, Vol. 72, Núm. 5, pp. 1758-1770

  6. The involvement of ADAM10 in acantholysis in mucocutaneous pemphigus vulgaris depends on the autoantibody profile of each patient

    British Journal of Dermatology, Vol. 182, Núm. 5, pp. 1194-1204

2019

  1. A novel concept to include uncertainties in the evaluation of stereotactic body radiation therapy after 4D dose accumulation using deformable image registration

    Medical Physics, Vol. 46, Núm. 10, pp. 4346-4355

  2. Identification of mutations associated with acquired resistance to sunitinib in renal cell cancer

    International Journal of Cancer, Vol. 145, Núm. 7, pp. 1991-2001